an important biomarker of Alzheimer's disease pathology easily measured with a blood test." Ms. Ricciardi concluded: "In addition to the substantial progress we have made with CT1812 in Alzheimer's ...
Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from healthcare providers and payers in the U.S.UK ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...